$149M&A Pre-Acquisition Check — Protect millions before you sign. Instant report.Run a Check →
Bridge BioHealth team
Our Story

Built by Scientists.
Led by Strategy.
Driven by Impact.

Bridge BioHealth was founded on a simple but powerful belief: the gap between scientific discovery and real-world impact is a solvable problem — if you have the right team.

Ph.D. Pharmaceutical SciencesMBA StrategyRN · NP CandidateMPH Public HealthMulti-Omics ExpertiseFDA RegulatoryFederal Contracting
Our Mission

Bridging the Gap Between
Discovery and Impact.

Bridge BioHealth Consulting LLC was born from frustration — the kind that comes from watching brilliant science stall at the intersection of regulatory complexity, business inexperience, and resource fragmentation.

Our founders — PhD-level pharmaceutical scientists, registered nurses, nurse practitioner candidates, public health professionals, and MBAs — came together with a unified mission: make the path from lab bench to patient bedside shorter, cheaper, and more equitable.

We don't just consult. We build. We connect. We share. And through the BioShare Marketplace, we're creating an entirely new economy of scientific collaboration — where a compound library sitting idle at a university can become the breakthrough a startup needs to save lives.

The Bridge Philosophy
Science without strategy stalls. Strategy without science fails. Wellness without both is unsustainable. We bridge all three.

Science First

Every recommendation we make is grounded in peer-reviewed evidence and real-world pharmaceutical experience. We never guess — we know.

Reduce Friction

Drug development is slow, expensive, and fragmented. We exist to remove the barriers — regulatory, operational, financial, and human.

Collaborative by Design

We built the BioShare Marketplace because we believe science advances faster when resources flow freely between labs, companies, and disciplines.

Integrity Always

We operate with full transparency on fees, IP arrangements, and conflicts of interest. Your trust is our most valuable asset.

The Team

World-Class Credentials.
Real-World Results.

Our team spans pharmaceutical R&D, clinical nursing, public health, genomics, and MBA-level business strategy.

Dr. Amara Osei-Bonsu
Dr. Amara Osei-Bonsu
Ph.D. Pharmaceutical Sciences · MBA
Founder & Chief Scientific Officer

Over 15 years in pharmaceutical drug discovery and development. Former senior scientist at two top-10 pharma companies. Expert in small molecule drug design, multi-omics data integration, and IND-enabling studies. Led programs from target identification through Phase II clinical trials.

Drug DesignMulti-OmicsIND StrategyCRO Management
Dr. Marcus Chen
Dr. Marcus Chen
Ph.D. Biochemistry · MBA (Wharton)
Co-Founder & CEO

Wharton MBA combined with a Ph.D. in Biochemistry from Johns Hopkins. Former biotech startup founder (acquired 2019). Deep expertise in federal contract acquisition (SBIR/STTR), go-to-market strategy for biotech products, and building investment-ready operations from the ground up.

Federal ContractsGTM StrategyInvestor RelationsOperational Scaling
Dr. Priya Nair
Dr. Priya Nair
Ph.D. Genomics · MPH
Director of Omics & Data Science

Dual expertise in genomics and public health. Former faculty at UCSF with 40+ peer-reviewed publications in multi-omics integration, biomarker discovery, and population genomics. Leads our data science practice and the genomic data sharing arm of the BioShare Marketplace.

GenomicsProteomicsBiomarker DiscoveryPublic Health
Jordan Williams
Jordan Williams
RN · NP Candidate · MPH
Director of Health Coaching & Clinical Strategy

Registered Nurse with 10+ years of clinical experience across oncology and internal medicine. Currently completing NP certification. MPH from Columbia Mailman School of Public Health. Leads our evidence-based health coaching programs and clinical validation pipeline support.

Clinical NursingHealth CoachingPublic HealthClinical Trials
Dr. Rafael Morales
Dr. Rafael Morales
Ph.D. Medicinal Chemistry · MBA
Director of Regulatory Affairs & CRO Strategy

Former FDA reviewer turned industry consultant. 12 years navigating IND, NDA, and BLA submissions. Expert in CRO selection, contract negotiation, and regulatory strategy for small molecules and biologics. Has successfully guided 20+ programs through FDA pre-submission meetings.

FDA RegulatoryCRO NegotiationIND/NDA/BLADrug Chemistry
Dr. Keisha Thompson
Dr. Keisha Thompson
Ph.D. Pharmacology · MPH
Director of Drug Screening & Compound Libraries

Expert in high-throughput screening, assay development, and compound library curation. Former HTS lead at a major academic drug discovery center. Oversees the compound library and screening services arm of the BioShare Marketplace, connecting labs with the resources they need.

HTSAssay DevelopmentCompound LibrariesPharmacology

Collective Credentials

The depth of expertise behind every Bridge BioHealth engagement

6
Ph.D. Scientists
2
MBAs (incl. Wharton)
2
MPH Professionals
1
RN · NP Candidate
Our Journey

From Frustration to
Industry-Defining Platform.

2019

The Frustration That Started It All

Our founders — working across pharma, academia, and clinical settings — kept hitting the same wall: brilliant science stalling due to regulatory confusion, business inexperience, and fragmented resources. The idea for Bridge BioHealth was born.

2019

The Frustration That Started It All

Our founders — working across pharma, academia, and clinical settings — kept hitting the same wall: brilliant science stalling due to regulatory confusion, business inexperience, and fragmented resources. The idea for Bridge BioHealth was born.

2020

Bridge BioHealth Founded

Officially incorporated as Bridge BioHealth Consulting LLC. First clients: two biotech startups navigating IND applications and a university lab seeking CRO partnerships. Both succeeded.

2020

Bridge BioHealth Founded

Officially incorporated as Bridge BioHealth Consulting LLC. First clients: two biotech startups navigating IND applications and a university lab seeking CRO partnerships. Both succeeded.

2021

Federal Contracting Practice Launched

Expanded into SBIR/STTR grant writing and federal contract acquisition. Secured $2.1M in federal funding for clients in the first year. Hired our first MBA-led business strategy team.

2021

Federal Contracting Practice Launched

Expanded into SBIR/STTR grant writing and federal contract acquisition. Secured $2.1M in federal funding for clients in the first year. Hired our first MBA-led business strategy team.

2022

Health Coaching Division Added

Recognized that burnout and poor wellness infrastructure were silently killing biotech productivity. Launched evidence-based health coaching for individuals and organizations. 500+ clients served.

2022

Health Coaching Division Added

Recognized that burnout and poor wellness infrastructure were silently killing biotech productivity. Launched evidence-based health coaching for individuals and organizations. 500+ clients served.

2023

BioShare Marketplace — Beta Launch

Launched the beta version of the BioShare Marketplace — the first platform dedicated to scientific resource sharing across academia and industry. 200+ listings in the first 90 days.

2023

BioShare Marketplace — Beta Launch

Launched the beta version of the BioShare Marketplace — the first platform dedicated to scientific resource sharing across academia and industry. 200+ listings in the first 90 days.

2024

Full Marketplace Launch & Expansion

BioShare Marketplace goes live with 795+ listings, IP trading, fee-based transactions, and compound library sharing. Partnerships with 40+ labs across 15 states. $2M+ in cost savings enabled.

2024

Full Marketplace Launch & Expansion

BioShare Marketplace goes live with 795+ listings, IP trading, fee-based transactions, and compound library sharing. Partnerships with 40+ labs across 15 states. $2M+ in cost savings enabled.

2025

Next Chapter: Global Reach

Expanding internationally. Building AI-powered resource matching for the marketplace. Launching the Bridge BioHealth Fellowship for early-career scientists from underrepresented backgrounds.

2025

Next Chapter: Global Reach

Expanding internationally. Building AI-powered resource matching for the marketplace. Launching the Bridge BioHealth Fellowship for early-career scientists from underrepresented backgrounds.

By the Numbers

Impact That Speaks for Itself.

50+
Drug Programs Advised
$8M+
Client Funding Secured
795+
Marketplace Listings
500+
Individuals Coached

Want to Work With Us?

Whether you're a client, a collaborator, or a scientist who wants to join our team — we'd love to connect.

Talk with Us